Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma

Fig. 6

ROC analysis of the sensitivity and specificity for survival prediction by lncRNA-based risk model and 17-gene prognostic model. The time-dependent ROC curve was used to evaluate the prognostic performance for survival prediction. Performance comparison was assessed between four-lncRNA signature and 17-gene signature by calculating the area under the ROC curves (AUC) in three datasets

Back to article page